晚期食管鳞癌-话题@MedSci

#晚期食管鳞癌#

7篇内容 | 1584人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=2183456, encodeId=3cd1218345684, content=<a href='/topic/show?id=db0c5989656' target=_blank style='color:#2F92EE;'>#晚期食管鳞癌#</a> <a href='/topic/show?id=fc2be734870' target=_blank style='color:#2F92EE;'>#纳武利尤单抗#</a> <a href='/topic/show?id=02bb11036040' target=_blank style='color:#2F92EE;'>#ASCO GI 2024#</a>, objectTitle=ASCO GI 2024：纳武利尤单抗+化疗和纳武利尤单抗+伊匹木单抗用于晚期食管鳞癌（ESCC）一线治疗的临床疗效（ CheckMate 648研究）, objectType=article, longId=810645, objectId=dac28106454b, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/20240122/1705890201768_8624274.png, objectUrl=/article/show_article.do?id=dac28106454b, replyNumber=0, likeNumber=210, createdTime=2024-01-23, rootId=0, userName=梅斯管理员, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=上海, moduleDTOList=[ModuleDTO(moduleId=dac28106454b, moduleTitle=ASCO GI 2024：纳武利尤单抗+化疗和纳武利尤单抗+伊匹木单抗用于晚期食管鳞癌（ESCC）一线治疗的临床疗效（ CheckMate 648研究）, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=dac28106454b)], followStatus=false, userIsMember=false, type=null, lengthMark=0), GetTopicListResponse(id=1614745, encodeId=8c4c1614e4584, content=<a href='/topic/show?id=db0c5989656' target=_blank style='color:#2F92EE;'>#晚期食管鳞癌#</a>, objectTitle=Clin Cancer Res：纳武单抗可显著延长晚期食管鳞癌的长期生存期, objectType=article, longId=301037, objectId=1d0d30103eaf, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=1d0d30103eaf, replyNumber=0, likeNumber=80, createdTime=2022-03-19, rootId=0, userName=1249883fm18暂无昵称, userId=823819536480, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=1d0d30103eaf, moduleTitle=Clin Cancer Res：纳武单抗可显著延长晚期食管鳞癌的长期生存期, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=1d0d30103eaf)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1614744, encodeId=c4551614e4496, content=<a href='/topic/show?id=db0c5989656' target=_blank style='color:#2F92EE;'>#晚期食管鳞癌#</a>, objectTitle=Lancet Gastroenterol Hepatol：郑大一附院王峰教授CAP 02研究显示卡瑞利珠单抗联合阿帕替尼二线治疗晚期食管鳞癌疗效显著, objectType=article, longId=293995, objectId=58f82939954d, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=58f82939954d, replyNumber=0, likeNumber=84, createdTime=2022-01-16, rootId=0, userName=1249883fm18暂无昵称, userId=823819536480, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=58f82939954d, moduleTitle=Lancet Gastroenterol Hepatol：郑大一附院王峰教授CAP 02研究显示卡瑞利珠单抗联合阿帕替尼二线治疗晚期食管鳞癌疗效显著, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=58f82939954d)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1614743, encodeId=1b241614e4374, content=<a href='/topic/show?id=db0c5989656' target=_blank style='color:#2F92EE;'>#晚期食管鳞癌#</a>, objectTitle=JAMA Surg：新辅助放化疗联合手术可显著改善中国局部晚期食管鳞癌患者的长期预后, objectType=article, longId=213435, objectId=f68521343500, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=f68521343500, replyNumber=0, likeNumber=64, createdTime=2021-06-30, rootId=0, userName=1249883fm18暂无昵称, userId=823819536480, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f68521343500, moduleTitle=JAMA Surg：新辅助放化疗联合手术可显著改善中国局部晚期食管鳞癌患者的长期预后, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=f68521343500)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1614742, encodeId=c7111614e42c1, content=<a href='/topic/show?id=db0c5989656' target=_blank style='color:#2F92EE;'>#晚期食管鳞癌#</a>, objectTitle=【ESMO速递】晚期食管鳞癌研究进展，免疫治疗再下一城, objectType=article, longId=181104, objectId=dde918110499, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=dde918110499, replyNumber=0, likeNumber=74, createdTime=2019-10-15, rootId=0, userName=1249883fm18暂无昵称, userId=823819536480, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=dde918110499, moduleTitle=【ESMO速递】晚期食管鳞癌研究进展，免疫治疗再下一城, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=dde918110499)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1614741, encodeId=b8711614e41ed, content=<a href='/topic/show?id=db0c5989656' target=_blank style='color:#2F92EE;'>#晚期食管鳞癌#</a>, objectTitle=【2019 ESMO】放化疗联合帕博利珠单抗治疗局部晚期食管鳞癌, objectType=article, longId=181035, objectId=c7c318103504, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=c7c318103504, replyNumber=0, likeNumber=96, createdTime=2019-10-14, rootId=0, userName=1249883fm18暂无昵称, userId=823819536480, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=c7c318103504, moduleTitle=【2019 ESMO】放化疗联合帕博利珠单抗治疗局部晚期食管鳞癌, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=c7c318103504)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1614740, encodeId=cf5c1614e4020, content=<a href='/topic/show?id=db0c5989656' target=_blank style='color:#2F92EE;'>#晚期食管鳞癌#</a>, objectTitle=晚期食管鳞癌一线PD-1单抗联合化疗获良效, objectType=article, longId=178525, objectId=35521e852530, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=35521e852530, replyNumber=0, likeNumber=84, createdTime=2019-09-03, rootId=0, userName=1249883fm18暂无昵称, userId=823819536480, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=35521e852530, moduleTitle=晚期食管鳞癌一线PD-1单抗联合化疗获良效, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=35521e852530)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1614739, encodeId=a4d51614e39c9, content=<a href='/topic/show?id=db0c5989656' target=_blank style='color:#2F92EE;'>#晚期食管鳞癌#</a>, objectTitle=Lancet Oncol：Nivolumab单抗或是化疗耐药后晚期食管鳞癌的新选择, objectType=article, longId=122114, objectId=14b712211476, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=14b712211476, replyNumber=0, likeNumber=65, createdTime=2017-12-04, rootId=0, userName=1249883fm18暂无昵称, userId=823819536480, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=14b712211476, moduleTitle=Lancet Oncol：Nivolumab单抗或是化疗耐药后晚期食管鳞癌的新选择, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=14b712211476)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

晚期食管鳞癌

2020-05-29

梅斯管理员

#晚期食管鳞癌# #纳武利尤单抗# #ASCO GI 2024#

ASCO GI 2024：纳武利尤单抗+化疗和纳武利尤单抗+伊匹木单抗用于晚期食管鳞癌（ESCC）一线治疗的临床疗效（ CheckMate 648研究）

2024-01-23发表于上海

1249883fm18暂无昵称

#晚期食管鳞癌#

Clin Cancer Res：纳武单抗可显著延长晚期食管鳞癌的长期生存期

2022-03-19

1249883fm18暂无昵称

#晚期食管鳞癌#

Lancet Gastroenterol Hepatol：郑大一附院王峰教授CAP 02研究显示卡瑞利珠单抗联合阿帕替尼二线治疗晚期食管鳞癌疗效显著

2022-01-16

1249883fm18暂无昵称

#晚期食管鳞癌#

JAMA Surg：新辅助放化疗联合手术可显著改善中国局部晚期食管鳞癌患者的长期预后

2021-06-30

1249883fm18暂无昵称

#晚期食管鳞癌#

【ESMO速递】晚期食管鳞癌研究进展，免疫治疗再下一城

2019-10-15

1249883fm18暂无昵称

#晚期食管鳞癌#

【2019 ESMO】放化疗联合帕博利珠单抗治疗局部晚期食管鳞癌

2019-10-14

1249883fm18暂无昵称

#晚期食管鳞癌#

晚期食管鳞癌一线PD-1单抗联合化疗获良效

2019-09-03

1249883fm18暂无昵称

#晚期食管鳞癌#

Lancet Oncol：Nivolumab单抗或是化疗耐药后晚期食管鳞癌的新选择

2017-12-04